These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 18082523)
1. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus. Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523 [TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study. Shargorodsky M; Michaelova K; Boaz M; Gavish D; Zimlichman R Diabet Med; 2007 Nov; 24(11):1254-60. PubMed ID: 17725634 [TBL] [Abstract][Full Text] [Related]
3. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)? Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222 [TBL] [Abstract][Full Text] [Related]
4. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent. Awadallah S; Hamad M Cytobios; 2000; 101(398):145-50. PubMed ID: 10755213 [TBL] [Abstract][Full Text] [Related]
6. Hypothesis--haptoglobin genotype and diabetic nephropathy. Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus. Ohnishi M; Fukui M; Ishikawa T; Ohnishi N; Ishigami N; Yoshioka K; Hasegawa G; Yoshikawa T; Nakamura N Metabolism; 2008 Dec; 57(12):1760-4. PubMed ID: 19013302 [TBL] [Abstract][Full Text] [Related]
8. Does adiponectin level explain the atherogenic properties of Hp 2-2 phenotype in type 2 diabetic patients? Frand J; Borislavsky A; Boaz M; Matas Z; Shargorodsky M Atherosclerosis; 2013 Jan; 226(1):146-8. PubMed ID: 23177015 [TBL] [Abstract][Full Text] [Related]
9. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Goldberg Y; Boaz M; Matas Z; Goldberg I; Shargorodsky M Clin Nutr; 2009 Feb; 28(1):21-5. PubMed ID: 19019502 [TBL] [Abstract][Full Text] [Related]
10. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445 [TBL] [Abstract][Full Text] [Related]
11. Arterial compliance: is it reduced in antiphospholipid syndrome? Reitblat T; Polishchuk I; Zamir D; Isakov I; Oren S J Hum Hypertens; 2006 Jul; 20(7):504-9. PubMed ID: 16625240 [TBL] [Abstract][Full Text] [Related]
12. Haptoglobin phenotype and vascular complications in patients with diabetes. Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324 [No Abstract] [Full Text] [Related]
13. [The influence of demographic and clinical parameters on arterial elasticity indices in families with hypertension and coronary artery disease]. Sedkowska A; Zukowska-Szczechowska E Przegl Lek; 2008; 65(6):261-7. PubMed ID: 18853655 [TBL] [Abstract][Full Text] [Related]
14. Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients. Wobeto VP; Rosim ET; Melo MB; Calliari LE; Sonati Mde F Diabetes Res Clin Pract; 2007 Sep; 77(3):385-8. PubMed ID: 17275123 [TBL] [Abstract][Full Text] [Related]
15. Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients. Kiyici S; Ersoy C; Kaderli A; Fazlioglu M; Budak F; Duran C; Gul OO; Sigirli D; Baran I; Tuncel E; Erturk E; Imamoglu S Diabetes Res Clin Pract; 2009 Oct; 86(1):44-50. PubMed ID: 19674806 [TBL] [Abstract][Full Text] [Related]
16. [The role of genetically determined haptoglobin phenotypes in patients with destructive pulmonary tuberculosis]. Kharakter ZhZ; Mazhak KD; Pavlenko AV Probl Tuberk; 1990; (7):50-2. PubMed ID: 2235952 [TBL] [Abstract][Full Text] [Related]
17. Arterial compliance in adolescents and young adults receiving chronic hemodialysis. Gbadegesin R; Kudelka T; Gadegbeku CA; Brophy P; Smoyer WE; Lin JJ Ren Fail; 2008; 30(6):591-6. PubMed ID: 18661408 [TBL] [Abstract][Full Text] [Related]
18. Haptoglobin polymorphism and mortality in patients with tuberculosis. Kasvosve I; Gomo ZA; Mvundura E; Moyo VM; Saungweme T; Khumalo H; Gordeuk VR; Boelaert JR; Delanghe JR; De Bacquer D; Gangaidzo IT Int J Tuberc Lung Dis; 2000 Aug; 4(8):771-5. PubMed ID: 10949330 [TBL] [Abstract][Full Text] [Related]
19. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus. Dalan R; Liuh Ling G Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294 [TBL] [Abstract][Full Text] [Related]
20. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]